Company intelligence / Profile preview

北京博瑞康健医药科技

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Beijing Borui Kangjian Pharmaceutical Technology is a professional Contract Research Organization (CRO) providing comprehensive clinical research services for the pharmaceutical and medical device industries. The company specializes in clinical trial management, regulatory registration, medical writing, data management, and statistical analysis. With a focus on high-quality standards and regulatory compliance, Borui Kangjian supports domestic and international clients in navigating the complex drug development landscape in China. Their expertise spans multiple therapeutic areas, ensuring efficient and reliable clinical development pathways.

Industry: Contract Research Organization

Beyond the preview

Go deeper on 北京博瑞康健医药科技.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 北京博瑞康健医药科技.

Explore the full profile